類天疱瘡重症度スコア(BPDAI) 17+
Takeda Pharmaceuticals International AG
专为 iPad 设计
-
- 免费
截屏
简介
・Outline
The purpose of this application is to allow the Bullous Pemphigoid Disease Area Index (BPDAI)*1, a severity assessment technique for pemphigoid, to be utilized in clinical sites and provide a wide variety of programs to manage the scores and display graphs of each patient. In addition, the anti-BP 180 antibody and anti-BP 230 antibody CLEIA index/ELISA index, and skin damage and itching (pruritus) scores (international criteria) can be managed simultaneously.
*1Advocated by the International Pemphigoid Committee.
・Features
* As a criterion guide for the numbers and sizes of erosions, bullae, urticarial lesions, and erythemas in each region is displayed, it is possible to enter data on the spot while examining the patient.
* A score chart (table and graph) for each patient can be displayed on the screen by a simple operation, and the chart can be used to explain the disease condition to the patient.
* The application includes a mail transmission function and a printout function (printers with AirPrint function) for transmitting (PDF file) or printing the scores entered and the score chart for each patient, so that the data can be included in the medical record.
* With regard to external use of management data, the data can be re-used in Excel by transmitting the data as an e-mail attachment (CSV format*2).*3
* With the management data import function, the management data entered in other places can be imported and re-used.*3
* The HELP function can be accessed from the screen.
*2The character code for CSV files is "S-JIS" in both Japanese and English.
*3The items in a CSV file created from management data do not include the patient ID information.
新内容
版本 1.0.4
Added support for iOS16.x
App 隐私
开发者“Takeda Pharmaceuticals International AG”已表明该 App 的隐私规范可能包括了下述的数据处理方式。有关更多信息,请参阅开发者隐私政策。
未收集数据
开发者不会从此 App 中收集任何数据。
隐私处理规范可能基于你使用的功能或你的年龄等因素而有所不同。了解更多
信息
- 提供者
- Takeda Pharmaceuticals International AG
- 大小
- 42.2 MB
- 类別
- 医疗
- 兼容性
-
- iPhone
- 设备需装有 iOS 12.0 或更高版本。
- iPad
- 设备需装有 iPadOS 12.0 或更高版本。
- iPod touch
- 设备需装有 iOS 12.0 或更高版本。
- Mac
- 需要 macOS 11.0 或更高版本以及装有 Apple M1 或更高版本芯片的 Mac。
- Apple Vision
- 设备需装有 visionOS 1.0 或更高版本。
- 语言
-
英语
- 年龄分级
- 17+ 频繁/强烈的医药或医疗信息
- Copyright
- © 2023 NIHON PHARMACEUTICAL Co., Ltd.
- 价格
- 免费